No Jab, No Job? Ethical Issues in Mandatory COVID-19 Vaccination of Healthcare Personnel.
No Jab, No Job? Ethical Issues in Mandatory COVID-19 Vaccination of Healthcare Personnel.
复制标题
DOI：
10.1136/bmjgh-2020-004877
复制
发表时间：
2021-03
影响因子：
8.1
通讯作者：
Kingori P
中科院分区：
文献类型：
--
作者：
Gur-Arie R;Jamrozik E;Kingori P
为HCP接种COVID-19疫苗有多复杂？从表面上看，为HCP接种COVID-19疫苗首先听起来很简单：医疗保健系统将收到COVID-19疫苗，将其分发给HCP，然后HCP将接种疫苗。尽管这种情况听起来似乎合理，但即使在COVID-19之前，全球公众和HCP对疫苗的犹豫也在以创纪录的速度上升。12 13先前的研究记录了HCP对COVID-19疫苗的疫苗犹豫的普遍性。14-17 HCP对COVID-19疫苗犹豫不决的潜在原因包括安全性担忧、对有效性的怀疑（在个体保护和/或减少传播方面）以及不治疗COVID-19患者的HCP认为感染风险较低。14类似因素导致HCP对季节性流感疫苗接种犹豫不决，18尽管有安全性和有效性的既定证据，但数十年来在某些环境中提高HCP的季节性流感疫苗接种率一直是一个有记录的挑战。18 19这就提出了一个问题：什么样的旨在增加HCP中COVID-19疫苗接种的政策在伦理上是合理的？毫无疑问，优先考虑HCP接种COVID-19疫苗的普遍共识是
HOW COMPLICATED CAN VACCINATING HCP AGAINST COVID-19 BE? On face value, vaccinating HCP against COVID-19 first sounds simple: healthcare systems will receive COVID-19 vaccines, distribute them to their HCP, and HCP will be vaccinated. Though such a scenario sounds plausible, vaccine hesitancy among the general public and HCP was rising globally at record rates even before COVID-19. 12 13 Previous research has documented the prevalence of vaccine hesitancy among HCP regarding COVID-19 vaccines. 14–17 Potential contributors to COVID-19 vaccine hesitancy among HCP include safety concerns, doubts about effectiveness (in terms of individual protection and/or reduction of transmission), and perceived low risks of infection among HCP who do not treat patients with COVID-19. 14 Similar factors contribute to vaccine hesitancy towards seasonal influenza vaccination among HCP, 18 which has been a documented challenge in raising seasonal influenza vaccine uptake among HCP in some settings for decades, despite established evidence of safety and effectiveness. 18 19 This raises the question: what kinds of policies aimed at increasing COVID-19 vaccine uptake among HCP would be ethically justifiable? Overarching consensus to prioritise HCP to receive COVID-19 vaccines is undoubtedly
登录
查看更多内容
影响因子：
4.5
作者：
Boas H;Rosenthal A;Davidovitch N
通讯作者：
Davidovitch N
DOI：
10.7196/samj.2020.v110i6.14901
发表时间：
2020-06-01
期刊：
SAMJ: South African Medical Journal
影响因子：
--
作者：
Dhai, A;Veller, M;Mokhachane, M
通讯作者：
Mokhachane, M
DOI：
10.1126/science.abe2803
发表时间：
2020-09-11
期刊：
Science (New York, N.Y.)
影响因子：
--
作者：
Emanuel EJ;Persad G;Kern A;Buchanan A;Fabre C;Halliday D;Heath J;Herzog L;Leland RJ;Lemango ET;Luna F;McCoy MS;Norheim OF;Ottersen T;Schaefer GO;Tan KC;Wellman CH;Wolff J;Richardson HS
通讯作者：
Richardson HS
影响因子：
82.9
作者：
Adam, Dillon C.;Wu, Peng;Cowling, Benjamin J.
通讯作者：
Cowling, Benjamin J.
影响因子：
4.9
作者：
Blank, Christopher;Gemeinhart, Nancy;Babcock, Hilary M.
通讯作者：
Babcock, Hilary M.